ENTITY
The United Laboratories International Holdings Limited

The United Laboratories International Holdings Limited (3933 HK)

47
Analysis
Health Care • Hong Kong
The United Laboratories International Holdings Limited produces and distributes pharmaceutical products. The Company's products include finished products, APIs, intermediates, and capsules.
more
bearish•Cross Asset Strategy
•30 Apr 2020 22:50

Screening the Silk Road: Q2 2020 Small-Mid Cap High Risk Names to Avoid

Deteriorating credit metrics continue to support our view that the level of risk is increasing within the small-mid cap universe.  Our screen...

Logo
547 Views
Share
bearish•MSCI ACWI Index
•27 Mar 2020 09:25

Global Equity Strategy: Initial Low Established

Several equity indexes and indicators we watch are telling us an initial primary low has been established for global equities (ACWI-US). At the...

Logo
566 Views
Share
bearish•Quantitative Analysis
•05 Dec 2019 00:07

Screening the Silk Road: Small-Mid Cap High Risk Names to Avoid: Q4 2019

* Our Q3-2019 Small-Mid Cap High-Risk list of stocks ( Screening the Silkroad: Small-Mid Cap High-Risk Names to Avoid: Q3 2019 )  produced a market...

Logo
546 Views
Share
bullish•MSCI ACWI Index
•22 Nov 2019 05:57

Global Equity Strategy: Health Care Hitting On All Cylinders - Overweight

Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the...

Logo
450 Views
Share
•26 Aug 2019 22:28

Screening the Silkroad: Small-Mid Cap High-Risk Names to Avoid: Q3 2019

Reduced List, but significant all the same OurQ2-2019 Small-Mid Cap High-Risk list of stocks (Screening the Silkroad: Small-Mid Cap High-Risk...

Logo
523 Views
Share
x